Fractionation in radiotherapy: A view from the clinic

British Journal of Radiology

Volumn 70, Issue SPECIAL.ISSUE, 1997, Pages

  Saunders, M I ^a   Dische, S ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0030696970     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.1997.0004     Document Type: Review

References (41)

1. Freund L. Ein mit Röntgen-Strahlen behandelter Fall von Naevus pigmentosus piliferus, Wien Med Wschr 1897;47:428-34.
2. Thames HD, Hendry JH. Fractionation in Radiotherapy. (London: Taylor & Francis, 1987).
3. Regaud C, Nogier T. Stérilisation rontgenienne totale et définitive, sans radiodermite, des testicules du bélier adulte; conditions de sa réalisation. C R Soc Biol 1911;70:202-3.
4. Bergonié J, Tribondeau L. Action des rayons X sur les spermatozoïdes de l'homme. C R Soc Biol 1904;57:595.
5. Dische S. The clinical science of radiation oncology. (Regaud Lecture, Malmö, 1992) Radiother Oncol 1993;28:93-107.
6. Coutard H. Röntgentherapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. AJR 1932;28:313-31.
7. Baclesse F. Carcinoma of the larynx. Br J Radiol Suppl. 3, 1949:1-63.
8. Wiernik G, Bates TD, Bleehen NM, et al. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1990;63:169-80.
9. Wiernik G, Alcock CJ, Bates TD, et al. Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1991;64:232-41.
10. Rezvani M, Fowler JF, Hopewell JW, Alcock CJ. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy. Br J Radiol 1993;66:245-55.
11. Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983;9:321-8.
12. Saunders MI, Dische S. Clinical fractionation studies. In Peckham M, Pinedo HM, Veronesi U, editors. Oxford Textbook of Oncology. Oxford: Oxford Medical Publications, 1995:796-811.
13. Begg AC, McNally NJ, Shrieve DC, Karcher MA. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985;6:620-6.
14. Wilson GD, McNally NJ, Dische S, Bennett MH. Cell proliferation in human tumours measured by in vivo labelling with bromodeoxyuridine. Br J Radiol 1988;61:419-22.
15. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
16. Strandqvist M. Studien über die kumulative Wirkung der Röntgenstrahlen bei Fraktionierung. Acta Radiol 1944;55:1-300.
17. Ellis F. Dose, time and fractionation: a clinical hypothesis. Clin Radiol 1969;20:1-7.
18. Barendsen GW. Dose fractionation, dose rate and iso-effect relationship for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8:1981-97.
19. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
20. Joiner MC. The linear-quadratic approach to fractionation. In GG Steel, editor. Basic Clinical Radiology. London: Edward Arnold, 1993:55-64.
21. Horiot J, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
22. Olmi P, Cellai E, Chiavacci A, Fallai C. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol 1990;17:199-207.
23. Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys 1981;7:99-104.
24. van der Schueren E, van den Bogaert W, Vanuytsel L, van Limbergen E. Radiotherapy by multiple fractions per day (MED) in head and neck cancer: Acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 1990;19:301-11.
25. van den Bogaert W, van der Schueren E, Horiot JC, et al The EORTC randomized trial on three fractions per day and misonidazole (trial no: 22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol 1995;35:100-6.
26. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial, Radiother Oncol 1997;44:111-21.
27. Overgaard J, Sand Hansen H, Sapru W, et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - preliminary report from the DAHANCA 6 and 7 trial. Radiother Oncol 1996;40 (Suppl. 1):S10.
28. Cummings BJ, Keane TJ, Pintillie M, et al. A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx. Radiother Oncol 1996;40 (Suppl. 1):S107.
29. Ang KK, Peters LJ, Weber RS, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990;19:1339-45.
30. Wang CC, Suit HD, Blitzer PH, et al. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1985;12:3-7.
31. Saunders MI, Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol 1986;59:523-5.
32. Saunders MI, Dische S, Grosch E, et al. Experience with CHART. Br J Radiol 1986;59:523-5.
33. Saunders MI, Dische S, Barrett A, et al. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. Br J Cancer 1996;73:1455-62.
34. Saunders MI, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 1997;350:161-5.
35. Dische S, Saunders MI, Barrett A, et al. A randomized multi-centre trial of CHART vs conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
36. Cox JD, Pajak TF, Marcial VA, et al. Astro Plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from radiation therapy oncology group protocol 8313. Int J Radiat Oncol Biol Phys 1991;20:1191-95.
37. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996;40:137-45.
38. van der Kogel AJ. The nervous system: radiobiology and experimental pathology. In Scherer E, Streffer C, Trott KR, editors. Radiopathology of Organs and Tissues. Heidelberg: Springer, 1991:191-212.
39. Dische S, Saunders MI, Bennett MH, et al. Cell proliferation and differentiation in squamous cancer. Radiother Oncol 1989;15:19-23.
40. Turner SL, Slevin NJ, Gupta NK, Swindell R. Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity - evaluation of late morbidity and a watch policy for the clinically negative neck. Radiother Oncol 1996;41:21-9.
41. Dische S, Saunders MI, Bennett MH, et al. Cell proliferation and differentiation in squamous cancer. Radiother Oncol 1989;15:19-23.